Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2023
The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overviewLisa M Verheul, Martijn H van der Ree, Sanne A Groeneveld, et al.
Circulation. Genomic and Precision Medicine|May 18, 2023
Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular ArrhythmiasCaroline Pham, Karolina Andrzejczyk, Sean J Jurgens, et al.
European Journal of Human Genetics : EJHG|July 11, 2018
Lack of evidence for a causal role of CALR3 in monogenic cardiomyopathyJudith M A Verhagen, Job H Veldman, Paul A van der Zwaag, et al.
Circulation. Genomic and Precision Medicine|September 30, 2022
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk StratificationMarijke H van der Meulen, Johanna C Herkert, Susanna L den Boer, et al.
European Heart Journal|April 5, 2011
Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategyImke Christiaans, Erwin Birnie, Gouke J Bonsel, et al.
European Journal of Heart Failure|July 24, 2012
Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathyPaul A van der Zwaag, Ingrid A W van Rijsingen, Angeliki Asimaki, et al.
European Heart Journal|October 27, 2015
Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriersGodelieve R F Claes, Florence H J van Tienen, Patrick Lindsey, et al.
Circulation|December 2, 2017
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O'Mahony, Fatima Jichi, Steve R Ommen, et al.
Human Mutation|March 1, 2020
A mutation update for the FLNC gene in myopathies and cardiomyopathiesJob A J Verdonschot, Els K Vanhoutte, Godelieve R F Claes, et al.
Pageof 7